| http://www.w3.org/ns/prov#value | - In contrast, in phase 2 there was an improvement in left ventricular ejection fraction (from 27.1???6.6% to 34.9???10.9%; P=0.001), increase in 6-minute walk distance (from 411???116 to 496???113 m; P=0.001), and a decrease in N-terminal pro B-type natriuretic peptide (from 3672???5165 to 1488???1847 pg/mL; P=0.04).
|
